Top Suppliers:I want be here
  • DC Chemicals Limited
  • China
  • Product Name: Umibecestat
  • Price: $Inquiry/100mg $Inquiry/250mg $Inquiry/1g
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

1387560-01-1

1387560-01-1 structure
1387560-01-1 structure
  • Name: Umibecestat
  • Chemical Name: Umibecestat
  • CAS Number: 1387560-01-1
  • Molecular Formula: C19H15ClF7N5O2
  • Molecular Weight: 513.80
  • Catalog: Signaling Pathways Neuronal Signaling Beta-secretase
  • Create Date: 2019-06-01 10:55:47
  • Modify Date: 2024-01-14 03:47:38
  • Umibecestat (CNP520) is a beta-site amyloid precursor protein cleaving enzyme-1 (BACE-1) inhibitor with IC50s of 11 nM and 10 nM for human BACE-1 and mouse BACE-1, respectively[1].

Name Umibecestat
Description Umibecestat (CNP520) is a beta-site amyloid precursor protein cleaving enzyme-1 (BACE-1) inhibitor with IC50s of 11 nM and 10 nM for human BACE-1 and mouse BACE-1, respectively[1].
Related Catalog
Target

IC50: 11 nM (human BACE-1), 10 nM (mouse BACE-1)[1]

In Vitro Umibecestat is a potent BACE-1 inhibitor that is selective for BACE-1 over other human pepsin-like aspartic proteases, including BACE-2 and cathepsin D[1].
In Vivo Umibecestat (1.5-51.3 mg/kg; given by oral gavage; 72 hours) shows a dose-dependent effects on Aβ40 and a long duration of action in both rat brain and CSF[1]. Umibecestat (3.1 mg/kg; oral administration; 7 days) shows a > 75% reduction on Aβ40 and Aβ42 in CSF after dosing and returns slowly to baseline over the next 7 days[1]. Animal Model: Male rats (3-4 months old)[1] Dosage: 1.5 mg/kg (3 μM/kg)-51.3 mg/kg (100 μM/kg) Administration: Given by oral gavage; 72 hours Result: Reduced 89.3±4.5% Aβ40 at the highest dose in brain tissue, and 50% lowering of rat brain Aβ40 (ED50) was 2.4±0.31 mg/kg. Reduced ~50% Aβ40 at a single oral 30 μM/kg (15.4 mg/kg) dose after 24 hours in both rat brain and CSF。 Animal Model: 3-month-old beagle dogs[1] Dosage: 3.1 mg/kg (6 μM/kg) Administration: Oral administration; 7 days Result: Both Aβ40 and Aβ42 concentrations in CSF showed a > 75% reduction at 12-48 h after dosing and returned slowly to baseline over the next 7 days.
References

[1]. Neumann U, et al. The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease. EMBO Mol Med. 2018 Nov;10(11). pii: e9316.

Molecular Formula C19H15ClF7N5O2
Molecular Weight 513.80